Literature DB >> 10392333

Comparative antimicrobial resistance and genomic diversity of Escherichia coli isolated from urinary tract infections in the community and in hospitals.

M Perrin1, P Y Donnio, C Heurtin-Lecorre, M F Travert, J L Avril.   

Abstract

Well-defined community- and nosocomially-acquired isolates of Escherichia coli responsible for urinary tract infections were studied for their resistance to beta-lactams, quinolones, and co-trimoxazole, antibiotics widely used for treatment of urinary infections. For each strain, an antibiogram was obtained using the Vitek automat, which estimates the minimal inhibitory concentrations of various drugs. Nosocomial strains were significantly more amoxycillin-resistant than community strains (P = 0.01) and were also significantly more resistant to co-trimoxazole (P = 0.025) and first generation quinolones (P = 0.02) than the latter. To determine whether this was due to transmission of strains within the hospital, DNA restriction patterns, established using XbaI enzyme and separation by pulsed-field gel electrophoresis, were compared. Extreme genomic diversity was found among both the community and nosocomial strains. The increased frequency of resistance among nosocomial strains is thus not due to transmission of resistant hospital strains but probably results from the selection of resistant strains from the endogenous flora of patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10392333     DOI: 10.1053/jhin.1998.0521

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  5 in total

1.  Virulence factors in Escherichia coli.

Authors:  James R Johnson
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

Review 2.  Defining relatedness in studies of transmission of antimicrobial-resistant organisms: variability in definitions across studies and impact of different approaches on study conclusions.

Authors:  Rachel M Greenblatt; Jennifer H Han; Irving Nachamkin; Pam Tolomeo; Ebbing Lautenbach
Journal:  Infect Control Hosp Epidemiol       Date:  2012-11-21       Impact factor: 3.254

3.  Impact of Changing Patterns of Antimicrobial Resistance in Uropathogens: Emerging Treatment and Strategies.

Authors:  Patricia D. Brown
Journal:  Curr Infect Dis Rep       Date:  2003-12       Impact factor: 3.725

4.  Five-Year Antimicrobial Resistance Patterns of Urinary Escherichia coli at an Australian Tertiary Hospital: Time Series Analyses of Prevalence Data.

Authors:  Oyebola Fasugba; Brett G Mitchell; George Mnatzaganian; Anindita Das; Peter Collignon; Anne Gardner
Journal:  PLoS One       Date:  2016-10-06       Impact factor: 3.240

5.  Antimicrobial drug use and resistance in Europe.

Authors:  Nienke van de Sande-Bruinsma; Hajo Grundmann; Didier Verloo; Edine Tiemersma; Jos Monen; Herman Goossens; Matus Ferech
Journal:  Emerg Infect Dis       Date:  2008-11       Impact factor: 6.883

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.